We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

1 hedge funds and large institutions have $513K invested in Singular Genomics Systems, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VCM
Virtue Capital Management
Tennessee
+$513K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VCM
1
Virtue Capital Management
Tennessee
$513K +$513K +3,651 New

OMIC Hedge Fund Activity: Q3 2025 in Review

1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q3 2025, worth a combined $513K.

Buyers outnumbered sellers: 1 fund opened new OMIC positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtue Capital Management, opening a new position worth an estimated $513K.

  • 1 institutional investor held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q3 2025, up from 0 in Q2 2025.
  • Funds reported $513K of Singular Genomics Systems, Inc. Common Stock stock for Q3 2025.
  • 1 fund opened new Singular Genomics Systems, Inc. Common Stock positions in Q3 2025 and 0 closed out, a net change of +1 holder.
  • The largest Singular Genomics Systems, Inc. Common Stock buyer in Q3 2025 was Virtue Capital Management, an estimated $513K added.

Based on aggregated 13F filings for Q3 2025.